Rugang Zhang

UT MD Anderson Cancer Center

NIH Rank #4101
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$2.3M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#4,101
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.3M across 6 grants · National rank #4101.

Top grants by award amount

Rugang Zhang's NIH grant portfolio, ranked by award amount.

  • 5R01CA276569-02R01
    Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
    $495.4K
    award amount
  • 5R01CA243142-05R01
    Regulation of tumor recurrence by stress activated neutrophils
    $489.7K
    award amount
  • 5R01CA260661-03R01
    Metabolic basis of ARID1A-mutated ovarian cancer
    $465.2K
    award amount
  • 5R01CA239128-06R01
    Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer
    $439.3K
    award amount
  • 5R01CA202919-09R01
    Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
    $360.4K
    award amount
  • 5P50CA281701-02P50
    The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
    $81.4K
    award amount

Affiliation

Institutions that have administered grants for Rugang Zhang.

Affiliated with UT MD Anderson Cancer Center (TX).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4101
  6. 2024
    Entered Top 25% Nationally
    Ranked #4101